Single-agent paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. London Gynaecological Oncology and North Thames Gynaecological Oncology Groups.

The aim of this study was to evaluate the efficacy of high-dose paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. Paclitaxel was administered intravenously over 3 h at a dose of 225 mg m(-2) on a 21-day cycle for six courses. Thirty-six patients were entered into t...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Gore, M. E., Rustin, G., Slevin, M., Gallagher, C., Penson, R., Osborne, R., Ledermann, J., Cameron, T., Thompson, J. M.
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group|1 1997
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2063326/
https://ncbi.nlm.nih.gov/pubmed/9043029
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires